LivaNova PLC has launched SenTiva DUO™, a new implantable pulse generator with a dual-pin header for VNS Therapy™ procedures. This recent IPG differs from the original SenTiva™, which is only available in a single-pin configuration with a dual-pin header. Patients who were first implanted with a dual-pin lead and IPG can now benefit from SenTiva DUO™, which marks the newest advancements in VNS Therapy technology.
SenTiva™ and SenTiva DUO™ both enable Day-Night Programming, Scheduled Programming, and can track rapid heart rate increases, low heart rates, and prone position events, which may be related to seizures.
We’re proud to offer SenTiva DUO to serve patients who were early adopters of VNS Therapy many years ago,” said Damien McDonald, Chief Executive Officer of LivaNova. “Over time, all VNS Therapy patients must replace their generators as batteries become depleted. Now, our ‘pioneer patients’ will be able to take advantage of the latest technology with SenTiva DUO and experience the full benefits of VNS Therapy, without the need to replace their dual-pin lead.”
Image Credit: LivaNova PLC
